Harbour Biomed 2021 Virtual Investor Forum On Highly Effective Innovation Engine Drives Value Creation


06/17/2021
8:00 am - 9:30 am EDT

Topics:
– Opening Remarks
– Company Overview
– Harbour Mice®: Industry Leading Platform Technology Generating Fully Human Monoclonal Antibodies
– Harbour Biomed Discovery Platform: Highly Effective Innovation Driver Fueling the Robust Internal Product Portfolio
– HBM4003: Next-Gen Anti-CTLA-4 Antibody with Potential to Be the Cornerstone of Immuno-Oncology Therapy
– Q & A